Proton Pump Inhibitor Therapy Does Not Affect Prognosis of Cirrhosis Patients With Acute Decompensation and Acute-on-Chronic Liver Failure: A Single-Center Prospective Study
Background: The aim of this study was to investigate the impact of proton pump inhibitor (PPI) therapy on complications and prognosis in cirrhosis patients with and without acute-on-chronic liver failure (ACLF).Materials and Methods: Cirrhosis patients with acute decompensation (AD) (n = 489) admitt...
Main Authors: | Shanshan Sun, Wenyi Ye, Ruihong Zhao, Jianhua Hu, Xuan Zhang, Meifang Yang, Hong Zhao, Jifang Sheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-11-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.763370/full |
Similar Items
-
The Clinical Courses and Prognosis of Cirrhotic Patients after First Acute Decompensation: Prospective Cohort Study
by: Jung Hee Kim, et al.
Published: (2023-12-01) -
Acute decompensation events differentially impact the risk of nosocomial infections and short-term outcomes in patients with cirrhosis
by: Xianbin Xu, et al.
Published: (2022-08-01) -
Risk Stratification Score to Predict Readmission of Patients With Acute Decompensated Cirrhosis Within 90 Days
by: Xiaomei Xu, et al.
Published: (2021-05-01) -
Role of precipitants in transition of acute decompensation to acute-on-chronic liver failure in patients with HBV-related cirrhosis
by: Tongyu Wang, et al.
Published: (2022-10-01) -
Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis
by: Jonel Trebicka, et al.
Published: (2019-03-01)